Adaptive Biotechnologies Corporation (ADPT)
NASDAQ·Healthcare·Biotechnology
$24.16
+4.46%
Mkt Cap $3.60B
Analyst Ratings
Buy
11
Hold
3
Sell
0
Price Target (13 analysts)
$21.25
Range $20.00 – $22.00
Implied Upside
-12.0%
Consensus $21.25 vs current $24.16